Verona Pharma

About Verona Pharma

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for chronic respiratory diseases. Our product candidate, ensifentrine, has shown significant improvements in lung function and reduced COPD exacerbations. Led by an experienced management team, we are listed on Nasdaq under VRNA. Headquartered in London, UK, with offices in Raleigh and Savannah, US.